Interferon-induced expression of MxA in the respiratory tract of rhesus macaques is suppressed by influenza virus replication

被引:25
作者
Carroll, Timothy D. [1 ,2 ]
Matzinger, Shannon R. [1 ,2 ]
Geneseca, Meritxell [1 ,2 ]
Fritts, Linda [1 ,2 ]
Colon, Roxana [1 ]
McChesney, Michael B. [1 ,3 ,4 ]
Miller, Christopher J. [1 ,2 ,5 ]
机构
[1] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA
[2] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA
[3] Univ Calif Davis, Dept Pathol, Davis, CA 95616 USA
[4] Univ Calif Davis, Lab Med, Sch Med, Davis, CA 95616 USA
[5] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA
关键词
D O I
10.4049/jimmunol.180.4.2385
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To determine the relationship between influenza A virus replication and innate antiviral immune responses, rhesus monkeys were given oseltamivir before influenza A/Memphis/7/01 (H1N1) challenge. We found that oseltamivir treatment significantly reduced viral replication in the trachea (p < 0.029). Further, in the trachea of both treated and untreated monkeys the mRNA levels of most innate antiviral molecules in the IFN-alpha beta pathway were dramatically increased by 24 h postinfection. However, the mRNA level of a single IFN-stimulated gene, MxA (myxovirus resistance A), the IFN-stimulated gene known to be critical in blocking influenza virus replication, was significantly lower in the tracheal lavages of untreated monkeys than in the oseltamivir-treated monkeys (p = 0.05). These results demonstrate for the first time that uncontrolled influenza A virus replication actively suppresses MxA gene expression and emphasize the critical role of innate immunity in controlling influenza virus replication in vivo.
引用
收藏
页码:2385 / 2395
页数:11
相关论文
共 60 条
[1]   Temporal and anatomic relationship between virus replication and cytokine gene expression after vaginal simian immunodeficiency virus infection [J].
Abel, K ;
Rocke, DM ;
Chohan, B ;
Fritts, L ;
Miller, CJ .
JOURNAL OF VIROLOGY, 2005, 79 (19) :12164-12172
[2]   Integrated molecular signature of disease: Analysis of influenza virus-infected macaques through functional genomics and proteomics [J].
Baas, T. ;
Baskin, C. R. ;
Diamond, D. L. ;
Garcia-Sastre, A. ;
Bielefeldt-Ohmann, H. ;
Tumpey, T. M. ;
Thomas, M. J. ;
Carter, V. S. ;
Teal, T. H. ;
Van Hoeven, N. ;
Proll, S. ;
Jacobs, J. M. ;
Caldwelll, Z. R. ;
Gritsenko, M. A. ;
Hukkanen, R. R. ;
Camp, D. G., II ;
Smith, R. D. ;
Katze, M. G. .
JOURNAL OF VIROLOGY, 2006, 80 (21) :10813-10828
[3]   Functional genomic and serological analysis of the protective immune response resulting from vaccination of Macaques with an NS1-Truncated influenza virus [J].
Baskin, C. R. ;
Bielefeldt-Ohmann, H. ;
Garcia-Sastre, A. ;
Tumpey, T. M. ;
Van Hoeven, N. ;
Carter, V. S. ;
Thomas, M. J. ;
Proll, S. ;
Solorzano, A. ;
Billharz, R. ;
Fornek, J. L. ;
Thomas, S. ;
Chen, C.-H. ;
Clark, E. A. ;
Murali-Krishna, Kaja ;
Katze, M. G. .
JOURNAL OF VIROLOGY, 2007, 81 (21) :11817-11827
[4]   MX GENES SHOW WEAKER PRIMARY RESPONSE TO VIRUS THAN OTHER INTERFERON-REGULATED GENES [J].
BAZZIGHER, L ;
PAVLOVIC, J ;
HALLER, O ;
STAEHELI, P .
VIROLOGY, 1992, 186 (01) :154-160
[5]   Role of apoptosis and cytokines in influenza virus morbidity [J].
Brydon, EWA ;
Morris, SJ ;
Sweet, C .
FEMS MICROBIOLOGY REVIEWS, 2005, 29 (04) :837-850
[6]   Immunological effects of the orally administered neuraminidase inhibitor oseltamivir in influenza virus-infected and uninfected mice [J].
Burger, RA ;
Billingsley, JL ;
Huffman, JH ;
Bailey, KW ;
Kim, CU ;
Sidwell, RW .
IMMUNOPHARMACOLOGY, 2000, 47 (01) :45-52
[7]   Safety and efficacy of intravenous zanamivir in preventing experimental human influenza A virus infection [J].
Calfee, DP ;
Peng, AW ;
Cass, LM ;
Lobo, M ;
Hayden, FG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (07) :1616-1620
[8]   Influenza and the challenge for immunology [J].
Doherty, PC ;
Turner, SJ ;
Webby, RG ;
Thomas, PG .
NATURE IMMUNOLOGY, 2006, 7 (05) :449-455
[9]   Zanamivir and oseltamivir: Two new options for the treatment and prevention of influenza [J].
Dreitlein, WB ;
Maratos, J ;
Brocavich, J .
CLINICAL THERAPEUTICS, 2001, 23 (03) :327-355
[10]   Hepatitis B virus downregulates the human interferon-inducible MxA promoter through direct interaction of precore/core proteins [J].
Fernández, M ;
Ouiroga, JA ;
Carreño, V .
JOURNAL OF GENERAL VIROLOGY, 2003, 84 :2073-2082